Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Indian Journal of Hematology and Blood Transfusion
Literature
1.
Chan A, Ignoffo RJ (2005) Survey of topical oral solutions for the treatment of chemo-induced oral mucositis. J Oncol Pharm Pract 11(4):139–143CrossRef
2.
Uberoi AS, Brown TJ, Gupta A (2019) Magic mouthwash for oral mucositis: a teachable moment. JAMA Intern Med 179(1):104–105CrossRef
3.
4.
Segre G, Hammarström S (1985) Aspects of the mechanisms of action of benzydamine. Int J Tissue React 7(3):187–193PubMed
5.
Dodd MJ, Dibble SL, Miaskowski C, MacPhail L, Greenspan D, Paul SM et al (2000) Randomized clinical trial of the effectiveness of 3 commonly used mouthwashes to treat chemotherapy-induced mucositis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 90(1):39–47CrossRef
Metadata
Title
Magical Myth of Magic Mouth Wash
Authors
Kamal Kant Sahu
Ajay Kumar Mishra
Akil Adrian Sherif
Publication date
01-10-2019
Publisher
Springer India
Published in
Indian Journal of Hematology and Blood Transfusion / Issue 4/2019
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-019-01098-6

Other articles of this Issue 4/2019

Indian Journal of Hematology and Blood Transfusion 4/2019 Go to the issue

Original Article

Distinct Clinical Features of Plasma Cell Myeloma Patients Exhibiting Dysmorphic Plasma Cells: Association with More Plasma Cells at Diagnosis

Short Communication

High Prevalence of Celiac Disease in Patients with Immune Thrombocytopenia

Original Article

Inhibition of γ/β Globin Gene Switching in CD 34+ Derived Erythroid Cells by BCL11A RNA Silencing

Review Article

The Metabolic Profiles in Hematological Malignancies

Original Article

Primary Plasma Cell Leukemia: A Retrospective Study of a Rare Disease From Tertiary Cancer Centre From India

Original Article

Performance Evaluation of Automated Immunohematology Analyzer IH-500 for Blood Bank Testing
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits